Sonnet BioTherapuetics(SONN) - 2021 Q2 - Quarterly Report

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2021 Commission File Number 001-35570 SONNET BIOTHERAPEUTICS HOLDINGS, INC. (Exact name of registrant as specified in the charter) incorporation or organization) Identification Number) Delaware 20-2932652 (State or other jurisdiction of (I.R.S. Employer 100 Overlook Center, Suite 102, Princeton, NJ 0 ...